R and Shiny for Cost-Effectiveness Analyses: Why and When? A Hypothetical Case Study

Rose Hart, Darren Burns, Bram Ramaekers, Shijie Ren, Daniel Gladwell, Will Sullivan, Niall Davison, Owain Saunders, Indeg Sly, Theresa Cain, Dawn Lee

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)765-776
Number of pages12
JournalPharmacoeconomics
Volume38
Issue number7
DOIs
Publication statusPublished - Jul 2020

Keywords

  • CURE FRACTION
  • VALIDATION

Cite this